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Abstract
Basic science studies at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) provided
important new information that has implications not only for treatment, but also for better understanding the
complex dynamics of HIV infection, epidemiology, and the impact of biology and genetics on vulnerability to HIV
infection, disease progression and the risk of vertical transmission. There was renewed interest in strategies on how
to eliminate residual viremia, bolster the immune system and potentially achieve viral eradication given recent
evidence that antiretroviral therapy (ART) is effective at minimizing viral reservoirs if administered early in acute
infection.
Discussion
Summarizing Track A reports, lead rapporteur Wendy
Burgers (University of Cape Town) highlighted invited
lectures on viral reservoirs and eradication, immune
activation, acute infection and cellular immunity [1]. In
the first of those four fields, Jean-Pierre Routy (McGill
University, Montreal) analyzed strategies to mobilize
reservoirs that contain virus beyond the reach of stan-
dard ART [2], including studies of valproic acid, histone
deacetylase inhibitors and NF-kappa-B-independent acti-
vators. He also reviewed work on interleukin-7 as an
agent to prevent viral latency and promote immune
reconstitution.
Routy concluded that early ART “represents the
easiest intervention to control reservoir size”, a concept
explored further by Joep Lange (University of Amster-
dam) [3]. Lange noted that a seminal study of viral
decay rates estimated it would take 7.7 years of suppres-
sive ART to eliminate HIV from resting CD4+ T cells
in blood, although HIV persistence at other sites, such
as the gut, may continually seed new reservoirs [4]. But
Lange maintained that treatment soon after infection
could make those reservoirs smaller. In an observational
study, all nine patients who began ART before HIV ser-
oconversion and six of eight who began within six
months of seroconversion had no detectable virus in cell
reservoirs, compared with all 17 comparison patients
who began ART during chronic HIV infection [5].
In a scientific keynote address, Nobel Laureate Fran-
çoise Barré-Sinoussi (Pasteur Institute, Paris) addressed
the issue of viral persistence in cellular reservoirs [6].
She proposed that ART may need to be started earlier
in the course of infection and followed with a discussion
of strategies that restore the immune system (to prevent
immune senescence) and that target residual infected
cells (to limit residual disease). Barré-Sinoussi, an IAS
Governing Council member, will chair a two-day basic
science workshop on controlling HIV reservoirs before
the next International AIDS Conference, scheduled for
July 2010 in Vienna.
IAS 2009 also featured several compelling studies on
genetic and cellular research affording new insights on
HIV infection risk in African women, viral loads in
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HIV-1 subtype C-infected people, breast milk transmis-
sion of HIV, and overall vertical transmission risk.
Biological factors behind HIV susceptibility and vertical
transmission
Comparing women in Kisumu, Kenya, and San Fran-
cisco, USA, Craig Cohen (University of California, San
Francisco) documented higher proportions and numbers
of activated CD4 cells, the primary target of HIV, in the
genital tract of women in Kisumu [7]. Until this study,
the higher HIV risk in African women than in women
elsewhere and in African men has been attributed pri-
marily to socio-behavioural and gender norms and to
high rates of sexually transmitted infections (STIs).
This study of 18- to 24-year-old women without HIV
or other STIs found significantly higher levels and/or
proportions of seven activated T-lymphocyte subtypes,
including activated CD4 and CD8 cells. Compared with
the 18 women in San Francisco, the 36 in Kisumu also
had significantly higher concentrations of a cytokine
that favours HIV transmission and significantly lower
concentrations of two immune factors that protect from
HIV. The investigators speculated that higher levels of
activated T-lymphocytes in African women may reflect
their greater exposure to pathogens, including parasites
and viruses.
Innovative research by Romain Marlin (Pasteur Insti-
tute, Paris) showed that cells of the maternal uterine
mucosa efficiently transfer HIV-1 to other cells, such as
placental cells (Figure 1) [8]. Yet HIV-1 transmission
remains rare in utero, especially during the first trime-
ster. To evaluate viral susceptibility and transmission in
the uterine mucosa, Marlin exposed mucosal cells to
HIV-1 that uses the CCR5 coreceptor or the CXCR4
coreceptor. The tissue tested came from HIV-negative
women who had elective abortions. CD14-expressing
cells proved the main target of CCR5-using HIV-1, the
type of virus usually involved in HIV-1 transmission.
Although infected CD14 cells produce low levels of
virus, they efficiently transfer virus to other cells. What
stifles viral transmission from the uterine mucosa to
placenta remains a mystery (Figure 1). Discovering the
factor or factors involved in preventing that transmis-
sion could offer clues important to other areas of
prevention research.
Genetic and cellular variables affecting HIV progression
and vertical transmission
In a study of 427 ART-naive Zulu and Xhosa people
infected with HIV-1 subtype C, the most prevalent sub-
type in the world, Boris Julg (Ragon Institute, Boston,
and University of KwaZulu-Natal) found that the 16
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Figure 1 Mechanisms of protection at a human mucosal barrier Source: Marlin R, et al: Antigen-presenting cells represent potential
targets for R5 tropic HIV-1 infection in the first trimester pregnancy human uterine mucosa. 5th IAS Conference on HIV Pathogenesis,
Treatment and Prevention: Cape Town, South Africa. MOAA204 [8]
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individuals (4%) expressing the HLA DRB1*1303 allele
had significantly lower viral loads than people without
that gene (about 8500 versus 43,000 HIV-1 RNA copies/
mL) [9]. The correlation held true after statistical adjust-
ment for expression of HLA B57. (HLA class II mole-
cules are involved in the presentation of antigens to
T cells.) The protective activity of the *1303 allele did
not correlate with increased T cell functional responses,
a finding suggesting that this allele may promote lower
viral loads by some alternative mechanism.
A study of lactating women found that CD4 cells
latently infected with HIV-1 and isolated in breast milk
can be spontaneously activated, even if ART makes
HIV-1 undetectable in blood [10]. Diane Valea (Centre
Muraz, Bobo Dioulasso, Burkina Faso) determined that
all blood and breast milk samples from six women tak-
ing ART and nine women taking a brief perinatal antire-
troviral regimen contained highly activated CD4+ T cells
that spontaneously secreted HIV-1 antigens and viral
RNA, regardless of whether HIV-1 RNA could be
detected in breast milk or blood. The findings suggest
an unsuspected HIV-1 cellular reservoir that could play
a pivotal role in viral transmission to breastfed infants.
In addition to maternal variables that affect risk of
vertical transmission, genetic factors in infants may
heighten their risk of infection, according to a study of
131 Kenyan infants by Robert Choi (University of
Washington, Seattle) [11]. Ninety-two infants (75%) had
the wild-type allele (C/C) at amino acid position 868 of
CD4; 37 infants (19%) had the heterozygous allele (C/T);
and two infants (5%) had the homozygous allele (T/T).
Thirty infants (23%) became infected, seven of them
after one month of age. Heterozygous infants had a two
times higher overall risk of HIV infection than wild-type
infants, and homozygous infants had a four times higher
overall risk. Heterozygosity or homozygosity raised the
risk of infection after one month (implicating breast
milk transmission) almost six times.
Conclusions
The highly productive and clinically relevant basic
research presented in Track A underlines the need for
greater funding and wider deployment of basic bench-
work initiatives in countries with high HIV prevalence.
The finding that women in sub-Saharan Africa have
more activated CD4 T cells in genital tract mucosa than
US women [7] demonstrates that: (1) basic research can
uncover unsuspected HIV risk correlations; and (2) beha-
vioural and cultural factors may not explain all, or even
most, of the heightened HIV risk in certain populations.
The study of uterine mucosal cell susceptibility to
HIV-1 illustrates the gaps that remain in understanding
vertical transmission of the virus [8]. Uncovering the
mechanism that limits vertical transmission in utero,
despite apparently efficient cell-to-cell transfer of the
virus, could have implications for prevention research
beyond vertical transmission.
The finding that an HLA class II genetic factor corre-
lates with lower HIV-1 loads in subtype C-infected peo-
ple [9] shows that much remains to be learned about
how genetic variables in diverse populations affect
HIV-1 disease progression. The discovery that HLA
DRB1*1303 exerts its influence on viral load indepen-
dently of T cell functional response emphasizes that
wider research in highly affected populations can expand
the understanding of innate HIV-specific immunity.
The breast milk study [10] may explain why even sup-
pressive ART does not completely stop HIV-1 transmis-
sion via breast milk, although Track B studies reviewed
in this supplement [11] suggest effective therapy can cut
breast milk transmission to less than 1%. Work should
continue to search for alternative vertical transmission
prevention strategies in antiretroviral-treated women
with or without detectable HIV-1 RNA in blood. Results
of the CD4 gene study [12] underline the importance of
learning more about genetic cofactors that influence
HIV-1 acquisition and progression as potential means of
improving prevention and treatment strategies.
Finally, Track A lead rapporteur Wendy Burgers [1]
suggested that reported findings that early ART can dra-
matically decrease the size of the latent HIV reservoir
underscore the call for universal treatment from early
stages of infection. Numerous studies in Track B add to
the already weighty evidence supporting use of ART ear-
lier in the course of HIV infection, particularly in coun-
tries that now use a CD4 threshold of 200 cells/mm3.
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